SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-350936
Filing Date
2012-08-13
Accepted
2012-08-13 06:16:01
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d355656d10q.htm 10-Q 340826
2 EX-31.1 d355656dex311.htm EX-31.1 9918
3 EX-31.2 d355656dex312.htm EX-31.2 10007
4 EX-32.1 d355656dex321.htm EX-32.1 2866
5 EX-32.2 d355656dex322.htm EX-32.2 2970
  Complete submission text file 0001193125-12-350936.txt   2964805

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alse-20120630.xml EX-101.INS 314103
7 XBRL TAXONOMY EXTENSION SCHEMA alse-20120630.xsd EX-101.SCH 37266
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alse-20120630_cal.xml EX-101.CAL 47875
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alse-20120630_def.xml EX-101.DEF 102328
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alse-20120630_lab.xml EX-101.LAB 284823
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alse-20120630_pre.xml EX-101.PRE 192850
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-06533 | Film No.: 121025970
SIC: 2834 Pharmaceutical Preparations